Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

SHA:605077 Revenue

Zhejiang Huakang Pharmaceutical had revenue of 1.19B CNY in the quarter ending March 31, 2026, with 45.35% growth. This brings the company's revenue in the last twelve months to 4.56B, up 52.47% year-over-year. In the year 2025, Zhejiang Huakang Pharmaceutical had annual revenue of 4.19B with 49.15% growth.

• Revenue (ttm): 4.56B
• Revenue Growth: +52.47%
• P/S Ratio: 1.13
• Revenue / Employee: 2.03M
• Employees: 2,248
• Market Cap: 5.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.19B	1.38B	49.15%
Dec 31, 2024	2.81B	25.74M	0.93%
Dec 31, 2023	2.78B	582.67M	26.48%
Dec 31, 2022	2.20B	606.01M	38.02%
Dec 31, 2021	1.59B	274.36M	20.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error